BriefCase

Aidoc's BriefCase is an artificial intelligence-powered software utilizing a deep-learning algorithm to analyze chest X-ray images from adult and transitional adolescent patients for suspected pneumothorax, aiming to enhance radiological triage. Its methodology involves processing DICOM images through a multi-component system (hospital server, cloud server, worklist application) to deliver timely, non-diagnostic notifications to clinicians, thereby facilitating prioritization within the standard clinical workflow without replacing direct image review.

Aidoc Medical's BriefCase is a radiological computer-aided triage and notification software designed for the analysis of Chest X-Ray images in adults and transitional adolescents aged 18 and older. Its purpose is to assist appropriately trained medical specialists in hospital networks with workflow triage by flagging and communicating suspected positive cases of Pneumothorax (Ptx). The methodology involves an artificial intelligence algorithm that analyzes DICOM images received and de-identified by an Aidoc Hospital Server, processed by an Aidoc Cloud Server, and then presented on an Aidoc Worklist Application; this system operates in parallel to standard image interpretation, providing notifications for suspect cases with compressed preview images intended for informational purposes only, not for diagnosis, and without altering the original medical image. The performance of BriefCase was evaluated in a retrospective, blinded, multicenter, multinational study using 619 chest X-ray cases (139 positive for Ptx, 480 negative), where the primary endpoint evaluating the software's ability to identify Pneumothorax yielded an Area Under the Curve (AUC) of 0.969, a sensitivity of 94.2%, and a specificity of 90.8%. A secondary endpoint measured the mean time-to-notification for true positive cases as 13.1 seconds, and the study also reported a Negative Predictive Value (NPV) of 99.3% and a Positive Predictive Value (PPV) of 53.3%, suggesting the software's potential to facilitate earlier attention to suspect cases.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the AI algorithm's performance vary across different X-ray machine manufacturers and image acquisition settings, particularly those underrepresented in the pivotal study's dataset (e.g., specific Philips, GE Healthcare, Siemens models beyond the overall distribution)?; Beyond time-to-notification, what is the quantifiable impact of BriefCase integration on radiologist reading times per case, overall report turnaround times, and instances of delayed diagnosis for critical Pneumothorax cases in real-world clinical practice?; Given the Positive Predictive Value of 53.3%, what is the typical number of false positive notifications a radiologist might encounter per shift in a busy emergency department, and how does this affect alert fatigue and trust in the system?; Can the BriefCase algorithm provide any indication of Pneumothorax size or type (e.g., tension vs. simple), and how does its sensitivity and specificity break down for subtle or small Pneumothoraces compared to larger, more obvious ones?; What are the specific data characteristics (e.g., image quality parameters, patient demographic shifts, prevalence of co-occurring pathologies) that would trigger a need for retraining or recalibration of the BriefCase AI model to maintain its stated performance levels?